Multiplexed High Content Hepatotoxicity Assays using iPSC-Derived Hepatocytes
18 Sep 2012

Human hepatocytes derived from stem cells can greatly accelerate the development of new chemical entities and improve drug safety by offering more clinically relevant cell-based models than those presently available. Human induced pluripotent stem cell (iPSC) derived hepatocytes express appropriate hepatocyte markers and demonstrate intrinsic hepatocyte functions similar to primary cells. We demonstrate several models for assessing general and specific hepatotoxicity that are well-suited for automated screening environments.

Molecular Devices®



Show    per page
1 of 9 Page     1 2 3  ... Next 
Advanced GPC Technology as a Part of Solving Complex Polymer Problems25 Nov 2014Read
Issues of Color in Histology in Medicine20 Nov 2014Read
Reprogramming of Somatic Cells to Pluripotency Under Low O2 Conditions20 Nov 2014Read
Instrument performance verification in laser diffraction11 Nov 2014Read
From Daltons to Megadaltons on a Single Mass Spectrometry Platform: UHR-qTOF for Biopharmaceuticals Analysis11 Nov 2014Read
Powering power plants with online particle size analysis11 Nov 2014Read
How to characterize and optimize inkjet inks - Part 111 Nov 2014Read
How to characterize and optimize inkjet inks Part 211 Nov 2014Read
Pharmaceuticals - When size is not enough11 Nov 2014Read
Exploring the role of SEC-MALS in protein and polymer characterization11 Nov 2014Read